Physician profile
Thomas A Franey
NPI 1184667222
$1,059.44
in general payments reported to CMS, 2019-2025
24 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $56.80 · 2021: $52.87 · 2022: $70.20 · 2023: $76.36 · 2024: $396 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $192.63 | 2023-2025 | Restrata Wound Matrix |
| Davol INC. | $135.93 | 2020-2024 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $114.40 | 2019-2021 | |
| Teleflex LLC | $66.18 | 2024-2025 | Quikclot, Deknatel |
| Integra Lifesciences Corporation | $52.68 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Melinta Therapeutics, LLC | $47.03 | 2025 | Kimyrsa, Orbactiv |
| Tela Bio, INC. | $45.83 | 2024 | Ovitex 2s |
| Smith+Nephew, INC. | $43.46 | 2024 | Oasis |
| Hologic Sales and Service, LLC | $39.97 | 2024 | Trident Specimen Radiography System, Trunode, Localizer |
| Mimedx Group, INC. | $34.10 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $30.34 | 2023 | Seglentis |
| Innocoll Pharmaceuticals Limited | $29.88 | 2021-2022 | |
| Olympus America INC. | $29.23 | 2019 | |
| Aroa Biosurgery Incorporated | $23.81 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $21.00 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $20.76 | 2024 | Novosorb Btm |
| Allergan, INC. | $20.27 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.33 | 2022 | |
| Mozarc Medical US LLC | $18.17 | 2023 | Palindrome |
| Medline Industries LP | $16.23 | 2019 | |
| W. L. Gore & Associates, INC. | $15.94 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $15.41 | 2024 | Dextile |
| Acell, INC. | $14.44 | 2020 | |
| Medtronic USA, INC. | $13.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Franey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.